Jump to navigation
The latest clinical and political news for Australian Endocrinologists
It's not as simple as type 1 and type 2, the authors posit
A diagnosis aids deliberation over treatment, according to expert reviewers.
We need to know more about the impact of changing hormonal status, researchers say.
OTC products threaten the health of many gym enthusiasts, researchers warn.
A hospital audit shows a poor rate of osteoporosis prevention.
Endocrinology and endocrine pathology item numbers set for change
Perth study drills down on cut-offs for reflex free T4 testing.
Professor Davis is limbering up for Melbourne's Around the Bay charity cycle.
Insulin management varies widely between regions.
Restrictions may be too complex.
One drug apears to be being used contrary to product indications.
Melbourne study reassures.
Manufacturer says decsion is not related to a safety issue.
Vitamin has been overhyped, an expert says.
The effect on clinical practice could be "substantial"
Supplies not relaible until mid-2017 says manufacturer
The majority of patients revert to euthyroidism without treatment.
Prescribing vitamin D for osteoporosis is one of the new 'do not do' recommendations.
An audit finds wide variation in the ordering of thyroid function tests..
Women with polycystic ovary syndrome are waiting years for diagnosis
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.